Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells - C. Bryce Johnson, Bennett R. May, Brian P. Riesenberg, Samantha Suriano, Shikhar Mehrotra, Elizabeth Garrett-Mayer, Mohamed L. Salem, Emily K. Jeng, Hing C. Wong, Chrystal M. Paulos, John M. Wrangle, David J. Cole, Mark P. Rubinstein (The American Association for Cancer Research (AACR), 2018)
6273655
Keywords: WW-YZ